Skip to main content
. 2020 Jun 24;8(1):e000331. doi: 10.1136/jitc-2019-000331

Figure 1.

Figure 1

Swimmer plot of patients with mUM treated with ipilimumab +nivolumab. CR, complete response; PR, partial response; SD, stable disease; mUM, metastatic uveal melanoma.